Novel Pharmacological Treatments for Anorexia Nervosa

About this study

The Li-Transformative Hub for Research into Eating Disorders (Li-THRED) at Monash University is conducting a randomised controlled trial to investigate the effects of 3 repurposed medications on anorexia nervosa.

These medications include brexpiprazole, memantine, and zinc. It is hypothesised that these treatments will improve eating disorder symptoms as compared to placebo.

Research TeamProfessor Jayashri Kulkarni, Dr Eva Gregertsen, Dr Romi Goldschlager
InstitutionMonash University
Ethics Approval NumberHREC/101711/Alfred-2024
Funding SourcePhilanthropy
Project Start Date1 May 2024
Project End Date1 May 2027
ParticipantsIndividuals aged 16 and over living with anorexia nervosa (including in partial remission & atypical anorexia nervosa)
What is Involved5 visits to our research site in Melbourne over a 3 month duration + 1 additional visit 3 months after end of treatment.
Location607 St Kilda Road, Melbourne
Contact Details

THRED@monash.edu

See also

Enhancing an interactive resource for young neurodivergent people with an eating disorder receiving treatment in a paediatric inpatient service.

We want to know how an existing interactive resource can be enhanced to promote improved support for neurodivergent, paediatric inpatients, with eating disorders?

Read more

Eating Disorder Treatment Waitlist Cross-Sectional Survey

Are you on a waitlist for adult (18+) psychological treatment for an eating disorder in Australia?

Read more

Investigating cognitive factors related to eating disorders

You are invited to take part in this research investigating the role of cognitive flexibility, perfectionism and rumination in eating disorders and disordered eating behaviours.

Read more

Exploring relationships between emotions and eating behaviours.

Emotions and eating behaviours appear to be linked (such as in binge-eating), and this is part of the growing research in this area.

Read more